Islex Therapeutics

Islex Therapeutics is a healthcare company that develops precision therapies for diabetes. Its solution utilizes the natural islet-homing ability of a ZnT8 autoantibody to guide antibody-conjugated therapeutics to islets, enhancing drug efficacy at the disease site while minimizing off-target toxicity.